Shopping Cart
- Remove All
- Your shopping cart is currently empty
SKLB-23bb is an orally bioavailable HDAC6-selective inhibitor and also has microtubule-disrupting ability.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $48 | In Stock | |
5 mg | $143 | In Stock | |
10 mg | $208 | In Stock | |
25 mg | $337 | In Stock | |
50 mg | $472 | In Stock | |
100 mg | $653 | In Stock | |
200 mg | $888 | In Stock | |
1 mL x 10 mM (in DMSO) | $158 | In Stock |
Description | SKLB-23bb is an orally bioavailable HDAC6-selective inhibitor and also has microtubule-disrupting ability. |
Targets&IC50 | HDAC6:17 nM |
In vivo | In vivo efficacy evaluations of colorectal HCT116, acute myelocytic leukemia MV4-11, and B cell lymphoma Romas xenografts, SKLB-23bb more effectively inhibited the tumor growth than SAHA even at a 4-fold reduced dose or ACY-1215 at the same dose. SKLB-23bb is a potent oral anticancer candidate for selective HDAC6 inhibitor. |
Molecular Weight | 396.44 |
Formula | C21H24N4O4 |
Cas No. | 1815580-06-3 |
Smiles | COc1ccc(cc1OCCCC(=O)NO)N(C)c1nc(C)nc2ccccc12 |
Relative Density. | 1.271 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 32 mg/mL (80.72 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.